Related Experiment Videos
Cardiovascular disease in postmenopausal women: myths and reality
1Portland Cardiovascular Institute, Portland, Oregon 97210, USA.
Insights
Cardiovascular disease (CVD) is the leading cause of death for women, surpassing men by age 65. Increased focus on women's cardiovascular health is crucial for risk reduction and improved outcomes.
Area of Science:
- Cardiology
- Women's Health
- Public Health
Background:
- Cardiovascular disease (CVD) disproportionately affects women, representing the leading cause of mortality.
- Despite its impact, CVD in women receives inadequate attention from the public and healthcare providers.
- Trends show decreasing CVD deaths in men, but not yet in women.
Purpose of the Study:
- To highlight the significant impact of cardiovascular disease (CVD) on women.
- To underscore the need for increased focus on CVD prevention and risk modification in women.
- To address the disparities in CVD presentation, diagnosis, and prognosis between men and women.
Main Methods:
- Review of epidemiological data on cardiovascular disease (CVD) mortality in men and women.
- Analysis of differences in CVD presentation and prognosis between sexes.
- Assessment of current healthcare focus and risk modification strategies for women.
Main Results:
- By age 65, CVD mortality in women exceeds that of men by 11%.
- Women experience delayed diagnoses due to differing disease presentation compared to men.
- Risk modification strategies, including lifestyle changes and pharmaceutical interventions, are inadequately addressed in women.
Conclusions:
- Cardiovascular disease (CVD) is a critical health issue for women, demanding greater attention.
- Addressing the unique aspects of CVD in women is essential for improving health outcomes.
- Enhanced awareness and proactive healthcare are necessary to reduce CVD mortality in women.
Abstract:
Although cardiovascular disease (CVD) has traditionally been considered a disease that affects middle-aged men, it also has a profound effect on women. By age 65, the number of deaths from CVD in women surpasses deaths in men by 11%. Cardiovascular disease is the leading cause of mortality in women. Despite the impact of CVD, women as a group, as well as healthcare professionals, have not focused on this disease entity. As a result, women may not make adjustments that could reduce their risk for CVD, and healthcare professionals may not adequately counsel women on risk modification, which may include lifestyle changes and pharmaceutical intervention. Although there are many similarities, women differ from men in both disease presentation and prognosis for CVD. Because of the difference in presentation, diagnoses in women may be delayed, potentially causing further harm. Although the number of deaths caused by CVD has been decreasing in men, this trend has yet to be observed in women.